Grayscale Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.00 M
- Company Age 5 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.05 Cr
- Revenue Growth 16.10%
- Profit Growth -18.58%
- Ebitda 37.70%
- Net Worth 34.53%
- Total Assets -9.16%
About Grayscale Diagnostics
Grayscale Diagnostics Private Limited (GDPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 July 2019 (Five years and seven months 13 days old ). Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.05 Cr.
Vidit Gaur and Disha Pathak serve as directors at the Company.
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100UP2019PTC119111
- Company No.
119111
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jul 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Grayscale Diagnostics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Disha Pathak  | Director | 15-Jul-2019 | Current |
| Vidit Gaur | Director | 15-Jul-2019 | Current |
Financial Performance of Grayscale Diagnostics.
Grayscale Diagnostics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.1% increase. The company also saw a substantial fall in profitability, with a 18.58% decrease in profit. The company's net worth Soared by an impressive increase of 34.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Grayscale Diagnostics?
In 2023, Grayscale Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Qualm Healthcare Private LimitedVidit Gaur is a mutual person
Charges (Loans)
₹10.48 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Nov 2021 | Others | ₹4.98 M | Open |
| 03 Dec 2020 | Others | ₹4.50 M | Open |
| 25 Sep 2019 | Others | ₹1.00 M | Open |
How Many Employees Work at Grayscale Diagnostics?
Unlock and access historical data on people associated with Grayscale Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Grayscale Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Grayscale Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.